Consun Pharmaceutical Group Limited revenue reports
Consun Pharmaceutical Group Limited financial reports, Consun Pharmaceutical Group Limited annual revenue in 2024. When does Consun Pharmaceutical Group Limited report revenue?
Consun Pharmaceutical Group Limited total revenue, net income and dynamics of changes in Euro today
Consun Pharmaceutical Group Limited current income and income for the latest reporting periods. Net revenue Consun Pharmaceutical Group Limited is now 493 487 000 €. Information about net revenue is taken from open sources. Net income of Consun Pharmaceutical Group Limited today amounted to 144 951 000 €. The financial graph of Consun Pharmaceutical Group Limited shows the values and changes of such indicators: total assets, net income, net revenue. The financial report chart shows the values from 30/09/2018 to 31/12/2020. Consun Pharmaceutical Group Limited financial report on the graph shows the dynamics of assets.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2020
460 907 975.23 €
+1.23 % ↑
135 381 624.88 €
+17.68 % ↑
30/09/2020
460 907 975.23 €
+1.23 % ↑
135 381 624.88 €
+17.68 % ↑
30/06/2020
357 647 859.30 €
-18.616 % ↓
97 547 882.03 €
-16.268 % ↓
31/03/2020
357 647 859.30 €
-18.616 % ↓
97 547 882.03 €
-16.268 % ↓
30/06/2019
439 455 342.68 €
-
116 500 244.77 €
-
31/03/2019
439 455 342.68 €
-
116 500 244.77 €
-
31/12/2018
455 292 875.45 €
-
115 038 095.95 €
-
30/09/2018
455 292 875.45 €
-
115 038 095.95 €
-
Show:
to
Consun Pharmaceutical Group Limited financial report charts
The latest dates of Consun Pharmaceutical Group Limited financial statements available online: 30/09/2018, 30/09/2020, 31/12/2020. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Consun Pharmaceutical Group Limited is 31/12/2020. Gross profit Consun Pharmaceutical Group Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Consun Pharmaceutical Group Limited is 375 040 500 €
Consun Pharmaceutical Group Limited quarterly report dates
Cost of revenue Consun Pharmaceutical Group Limited is the total cost of producing and distributing of products and services of a company. Cost of revenue Consun Pharmaceutical Group Limited is 118 446 500 € Total revenue Consun Pharmaceutical Group Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Consun Pharmaceutical Group Limited is 493 487 000 € Operating income Consun Pharmaceutical Group Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Consun Pharmaceutical Group Limited is 151 706 500 €
Net income Consun Pharmaceutical Group Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Consun Pharmaceutical Group Limited is 144 951 000 € Current assets Consun Pharmaceutical Group Limited is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Consun Pharmaceutical Group Limited is 2 658 697 000 € Total assets Consun Pharmaceutical Group Limited refers to the total amount of assets owned by a person or entity. Total assets Consun Pharmaceutical Group Limited is 3 950 253 000 €
31/12/2020
30/09/2020
30/06/2020
31/03/2020
30/06/2019
31/03/2019
31/12/2018
30/09/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
350 281 076.27 €
350 281 076.27 €
266 927 385.69 €
266 927 385.69 €
320 889 129.72 €
320 889 129.72 €
342 017 670.53 €
342 017 670.53 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
110 626 898.96 €
110 626 898.96 €
90 720 473.61 €
90 720 473.61 €
118 566 212.95 €
118 566 212.95 €
113 275 204.92 €
113 275 204.92 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
460 907 975.23 €
460 907 975.23 €
357 647 859.30 €
357 647 859.30 €
439 455 342.68 €
439 455 342.68 €
455 292 875.45 €
455 292 875.45 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
141 691 140.28 €
141 691 140.28 €
115 213 217.57 €
115 213 217.57 €
151 712 767.14 €
151 712 767.14 €
160 973 665.66 €
160 973 665.66 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
135 381 624.88 €
135 381 624.88 €
97 547 882.03 €
97 547 882.03 €
116 500 244.77 €
116 500 244.77 €
115 038 095.95 €
115 038 095.95 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
319 216 834.95 €
319 216 834.95 €
242 434 641.72 €
242 434 641.72 €
287 742 575.53 €
287 742 575.53 €
294 319 209.79 €
294 319 209.79 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
2 483 175 141.45 €
2 483 175 141.45 €
2 182 686 046.58 €
2 182 686 046.58 €
2 425 132 830.06 €
2 425 132 830.06 €
2 237 965 639.21 €
2 237 965 639.21 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
3 689 465 197.45 €
3 689 465 197.45 €
3 402 891 500.39 €
3 402 891 500.39 €
3 919 536 719.43 €
3 919 536 719.43 €
3 639 763 345.32 €
3 639 763 345.32 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
1 812 180 057.09 €
1 812 180 057.09 €
1 420 738 861.07 €
1 420 738 861.07 €
1 327 859 021.08 €
1 327 859 021.08 €
1 185 919 908.57 €
1 185 919 908.57 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
1 383 233 879.87 €
1 383 233 879.87 €
933 190 917.25 €
933 190 917.25 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
1 509 369 082.96 €
1 509 369 082.96 €
1 307 599 083.53 €
1 307 599 083.53 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
38.51 %
38.51 %
35.93 %
35.93 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
2 073 782 811.39 €
2 073 782 811.39 €
1 892 810 723.15 €
1 892 810 723.15 €
2 083 024 563.28 €
2 083 024 563.28 €
2 014 803 716.06 €
2 014 803 716.06 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
65 307 757.37 €
65 307 757.37 €
168 781 755.18 €
168 781 755.18 €
Last revenue report of Consun Pharmaceutical Group Limited was 31/12/2020. According to last financial report total revenue in Consun Pharmaceutical Group Limited was 460 907 975.23 Euro and changed by +1.23% since last year. Net income in Consun Pharmaceutical Group Limited was 135 381 624.88 € in last quartal, net income changes to +17.68%.
Current cash Consun Pharmaceutical Group Limited - the sum of all of the cash a company has on the date of report. Current cash Consun Pharmaceutical Group Limited is 1 940 273 000 €
Consun Pharmaceutical Group Limited stocks data
C1P.F stock price
Consun Pharmaceutical Group Limited stock price today, C1P.F stock quote.
